Close Menu

NEW YORK – University of Michigan spinout InheRET said on Thursday that it has received a $2 million Small Business Technology Transfer grant from the National Cancer Institute to expand its Inherited Risk Evaluation Tool (InheRET) to identify patients at risk for hereditary disease.

Ann Arbor, Michigan-based InheRET will use the two-year grant, which was awarded Sept. 10, to further improve the platform, increase integration with electronic health records, and increase its workforce and end userbase.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to CNBC, Pfizer has announced that its SARS-CoV-2 vaccine data won't be ready this week.

A number of United Nations agencies push for scientific findings to be made accessible through open science.

Paris-Saclay University garners international regard following a decade-long effort to establish the new research university, Nature News reports.

In Nucleic Acids Research this week: database to house IndiGen sequencing data, database of SARS-CoV-2 docking scores, and more.